Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 250 movers: Pets at Home soars after upbeat results
(Sharecast News) - The FTSE 250 (MCX) was down 0.14% at 19,821.49 at1420 BST.
Pets at Home shares soared after the company reported an above-forecast jump in annual profits on Wednesday, driven by strong demand across the pet care market.
Revenues at the retail and veterinary business came in at £1.32bn, up 15.3% on the previous year, or 15.8% on a like-for-like basis. Retail sales rose 15.8% on a like-for-like basis, to £1.21bn, while vet group revenues increased 17.1% on the same basis, to £108.4m.
Underlying proforma pre-tax profits surged 65.3% to £144.7m, ahead of expectations for around £141m.
IT services provider Softcat gained as the company said annual operating profit would be slightly ahead of expectations after a strong third quarter.
The company said it delivered double-digit year-on-year growth in revenue, gross profit and operating profit in the three months to April 30 across all technology segments, "reflecting strong and stable customer demand". The supply chain situation remains challenging but consistent with the first half, Softcat added.
Shares in private hospital group operator Mediclinic were higher after the firm reported a jump in full-year operating profit on Wednesday, with revenues above pre-pandemic levels as client activity increased, as it reinstated its dividend.
In the year to the end of March, operating profit rose 34% to £280m, with revenues up 8% on the year to £3.2bn, and 5% higher versus pre-pandemic levels.
Group adjusted earnings per share came in at 22.6p, up 65% on the year, and Mediclinic proposed the reinstatement of its dividend at 3p a share.
Volution rallied after saying it continued to perform strongly through the second half, with third-quarter revenue growth of 17.6% at constant currency.
FTSE 250 - Risers
Pets at Home Group (PETS) 310.80p 10.68% Volution Group (FAN) 378.50p 6.47% SSP Group (SSPG) 257.40p 5.49% Softcat (SCT) 1,403.00p 4.08% Mediclinic International (MDC) 366.80p 3.32% Bridgepoint Group (Reg S) (BPT) 302.80p 2.85% Johnson Matthey (JMAT) 2,366.00p 2.78% Energean (ENOG) 1,376.00p 2.76% Centrica (CNA) 85.16p 2.41% PureTech Health (PRTC) 175.20p 2.34%
FTSE 250 - Fallers
Cranswick (CWK) 2,932.00p -6.45% Petrofac Ltd. (PFC) 151.00p -4.25% Trustpilot Group (TRST) 98.65p -4.04% Network International Holdings (NETW) 209.60p -4.03% Spectris (SXS) 2,927.00p -3.81% Chrysalis Investments Limited NPV (CHRY) 119.00p -3.72% Oxford Instruments (OXIG) 2,110.00p -3.65% Countryside Partnerships (CSP) 226.60p -3.57% Darktrace (DARK) 341.90p -3.55% RHI Magnesita N.V. (DI) (RHIM) 2,394.00p -3.31%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
